Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SOD1 | P00441 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28099874 | 0.94 | KMT2A (0.50) | KMT2AMAOBALDH1A1TSHRCYP3A4 | |
| SCHEMBL28033998 | 0.83 | ALDH1A1 (0.46) | KMT2AMAOBALDH1A1SOD1CYP1A2 | |
| SCHEMBL31490212 | 0.83 | SRC (0.44) | KMT2AMAOBALDH1A1SOD1TSHR | |
| SCHEMBL18037096 | 0.83 | SRC (0.58) | KMT2AMAOBALDH1A1TSHRCYP1A2 | |
| SCHEMBL18529819 | 0.82 | PARP1 (0.47) | KMT2AMAOBALDH1A1TSHRCYP1A2 | |
| SCHEMBL28074472 | 0.80 | ALDH1A1 (0.44) | KMT2AMAOBALDH1A1CYP1A2MAPK1 | |
| SCHEMBL3229774 | 0.79 | CYP3A4 (0.46) | CYP3A4 | |
| SCHEMBL78015 | 0.77 | SRC (0.54) | KMT2AALDH1A1TSHRCYP3A4CYP1A2 | |
| SCHEMBL25513746 | 0.77 | SRC (0.54) | KMT2AALDH1A1TSHRCYP3A4CYP1A2 | |
| SCHEMBL11722371 | 0.77 | CYP3A4 (0.52) | KMT2AALDH1A1SOD1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9920083-B2 | Image recording paper medium and image recording method | FUJIFILM CORPORATION (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20160250866-A1 | IMAGE RECORDING PAPER MEDIUM AND IMAGE RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2016-09-01 | — | — | US | disclosed |
| EP-0516212-A2 | Process for purifying polybrominated triaryl phosphate esters | FMC CORPORATION (US) | 1992-12-02 | — | — | EP | disclosed |
| EP-0516211-A1 | Process for preparing polybrominated triaryl phosphate esters | FMC CORPORATION (US) | 1992-12-02 | — | — | EP | disclosed |
| US-5138085-A | Dissolving crude tris (bromophenyl) phosphate in an ester, heating; cooling to crystallize | FMC CORPORATION (US) | 1992-08-11 | — | — | US | disclosed |
| US-5128496-A | Phosphorylation of bromophenol, hydrocarbon solvent | FMC CORPORATION (US) | 1992-07-07 | — | — | US | disclosed |
| US-4033927-A | PHOSPHONATES | GENERAL ELECTRIC COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160250866-A1 | IMAGE RECORDING PAPER MEDIUM AND IMAGE RECORDING METHOD | PHOSPHO1, ITPR2, PPIP5K2 | KMT2A 3383/4885MAOB 1345/4885ALDH1A1 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.